Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
ACS Chemical Neuroscience|August 24, 2018
Delivering Hematopoietic Stem Cell Gene Therapy Treatments for Neurological Lysosomal DiseasesRebecca J Holley, Shaun R Wood, Brian W Bigger
Biochemical Society Transactions|May 23, 2014
Using embryonic stem cells to understand how glycosaminoglycans regulate differentiationRebecca J Holley, Kate A Meade, Catherine L R Merry
Plos One|February 17, 2017
Identification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of Mucopolysaccharidosis Type IIHélène F E Gleitz, Claire O'Leary, Rebecca J Holley, et al.
Human Gene Therapy|July 10, 2023
Establishment of the Effectiveness of Early Versus Late Stem Cell Gene Therapy in Mucopolysaccharidosis II for Treating Central Versus Peripheral DiseaseOriana Mandolfo, Aiyin Liao, Esha Singh, et al.
Biochemical Society Transactions|January 27, 2011
Glycosaminoglycans as regulators of stem cell differentiationRaymond A A Smith, Kate Meade, Claire E Pickford, et al.
Molecular Genetics and Metabolism|July 26, 2024
Generation of a novel immunodeficient mouse model of Mucopolysaccharidosis type IIIA to test human stem cell-based therapiesOriana Mandolfo, Helen Parker, Asma'u Usman, et al.
Stem Cells (Dayton, Ohio)|February 11, 2011
Specific glycosaminoglycans modulate neural specification of mouse embryonic stem cellsClaire E Pickford, Rebecca J Holley, Graham Rushton, et al.
The Journal of Biological Chemistry|December 15, 2010
Influencing hematopoietic differentiation of mouse embryonic stem cells using soluble heparin and heparan sulfate saccharidesRebecca J Holley, Claire E Pickford, Graham Rushton, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 19, 2014
Use of flow cytometry for characterization and fractionation of cell populations based on their expression of heparan sulfate epitopesRebecca J Holley, Raymond A Smith, Els M A van de Westerlo, et al.
EMBO Molecular Medicine|June 10, 2018
Brain-targeted stem cell gene therapy corrects mucopolysaccharidosis type II via multiple mechanismsHélène Fe Gleitz, Ai Yin Liao, James R Cook, et al.
Pageof 3